The purpose of this study is to evaluate the immunogenicity and safety of mRNA-1283 and mRNA-1273 (variant formulations) within the current epidemiological env…

SARS-CoV-2

~Estimated

~$25 – $1,400

Actual pay is set by the research site.

ModernaTX, Inc.NCT07863635

Phase 3

A Phase 3 Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Secutrelvir in Participants With COVID-19 Who Are at High Risk for Progression to Severe Disease

The primary purpose of this study is to evaluate the efficacy and safety of secutrelvir in symptomatic nonhospitalized adult and adolescent participants with C…

SARS-CoV-2

~Estimated

~$50 – $2,250

Actual pay is set by the research site.

ShionogiNCT07743580

← PreviousPage 2 of 2Next →